LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Stock

Equities

2291

CNE1000057M5

Medical Equipment, Supplies & Distribution

Market Closed - Hong Kong S.E. 04:08:20 2024-04-16 am EDT 5-day change 1st Jan Change
23 HKD -4.37% Intraday chart for LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. -8.73% -15.44%

Financials

Sales 2021 223M 30.76M 241M Sales 2022 248M 34.22M 268M Capitalization 8.77B 1.21B 9.49B
Net income 2021 58M 8.01M 62.74M Net income 2022 -19M -2.63M -20.55M EV / Sales 2021 * -
Net cash position 2021 709M 97.92M 766M Net cash position 2022 1.2B 166M 1.3B EV / Sales 2022 30.6 x
P/E ratio 2021 *
-
P/E ratio 2022
-418 x
Employees 219
Yield 2021 *
-
Yield 2022
-
Free-Float 19.25%
More Fundamentals * Assessed data
Dynamic Chart
LEPU ScienTech Medical Adopts New Standard for Financial Reporting; Replaces Auditor MT
ScienTech Medical Turns Profitable in 2023 MT
LEPU ScienTech Medical Technology Co., Ltd. Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 30 September 2024 CI
LEPU ScienTech Medical Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
ScienTech Medical Forecasts Swing to Profit in 2023 MT
Lepu Scientech Medical Technology Co., Ltd. Provides Consolidated Earnings Guidance for the Year Ended December 31, 2023 CI
Lepu Scientech Medical Technology Co., Ltd. Announces Board Changes CI
LEPU ScienTech Medical Units Invest 100 Million Yuan in Bank of Ningbo’s Structured Deposit Products MT
Certain H Shares of LEPU ScienTech Medical Technology Co., Ltd. are subject to a Lock-Up Agreement Ending on 7-NOV-2023. CI
China Grants Medical Device Registration for LEPU ScienTech Unit's Heart Occluder MT
LEPU ScienTech Reports 213% Jump in H1 Profit; Shares Drop 4% MT
LEPU ScienTech Medical Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
LEPU ScienTech Medical Technology Co., Ltd. Announces Executive Changes CI
LEPU ScienTech Medical Technology Co., Ltd. Announces Change of Principal Place of Business in Hong Kong CI
LEPU ScienTech Expects Around 200% Surge in H1 Profit MT
More news
1 day-2.08%
1 week-6.55%
Current month-10.11%
1 month-18.23%
3 months-8.19%
6 months-18.79%
Current year-13.42%
More quotes
1 week
23.35
Extreme 23.35
25.70
1 month
23.35
Extreme 23.35
29.55
Current year
23.35
Extreme 23.35
29.80
1 year
23.35
Extreme 23.35
35.50
3 years
23.35
Extreme 23.35
43.00
5 years
23.35
Extreme 23.35
43.00
10 years
23.35
Extreme 23.35
43.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 52 21-01-28
Director of Finance/CFO 47 21-05-27
Chief Operating Officer 43 21-05-27
Members of the board TitleAgeSince
Director/Board Member 50 21-09-01
Director/Board Member 56 21-06-08
Director/Board Member 62 21-01-28
More insiders
Date Price Change Volume
24-04-16 23 -4.37% 96 000
24-04-15 24.05 -1.43% 88,000
24-04-12 24.4 +0.62% 84,000
24-04-11 24.25 -4.53% 93,000
24-04-10 25.4 +0.79% 86,000

Delayed Quote Hong Kong S.E., April 15, 2024 at 11:52 pm EDT

More quotes
Lepu Scientech Medical Technology Shanghai Co Ltd is a China-based investment holding company mainly engaged in the research and development, manufacturing and commercialization of interventional medical devices for structural heart disease. The Company operates primarily through two segments. The Occluder Business segment is mainly engaged in the research and development and sales of a series of interventional treatment series occluders for defective congenital heart disease. The Heart Valve Business segment is mainly engaged in the research and development of heart valve medical devices. The Company operates primarily in the domestic market.
More about the company